Modified Fangji Huangqi Decoction ameliorates IgA nephropathy by enriching Fusicatenibacter saccharivorans to rebalance Th17/Treg

Background Abnormalities in mucosal immunity caused by gut microbiota dysbiosis are one of the key factors in the pathogenesis of IgA nephropathy (IgAN). Modified Fangji Huangqi Decoction (MFHD) is an effective treatment for IgAN, but it remains unclear whether its therapeutic effect is mediated by modulating the gut microbiota and thereby influencing mucosal immunity.Methods The chemical composition of MFHD was analyzed using UPLC-MS/MS. The renoprotective effects of different doses of MFHD on IgAN mice were evaluated by examining renal pathology and laboratory parameters. Additionally, a combination of metagenomics, flow cytometry, ELISA, and Western blot techniques was used to evaluate the effects of MFHD on the gut microbiota–mucosal immune axis. Potential functional bacterial species were identified through correlation analysis, and their effects were validated through strain transplantation experiments in a pseudo-germ-free mouse model.Results MFHD reduces urinary protein and improves renal pathological damage in IgAN mice. MFHD significantly increases gut microbiota diversity, enriches beneficial bacteria, and reverses the Th17/Treg immune imbalance, thereby reducing IgA+ plasma cells and serum IgA and IgG levels. Correlation analyses and strain transplantation experiment further confirmed that intestinal colonization by Fusicatenibacter saccharivorans restores the Th17/Treg balance and inhibits the differentiation of IgA+ plasma cells, thereby exerting a renoprotective effect. Additionally, both MFHD and Fusicatenibacter saccharivorans increase the expression of occludin and ZO-1, thereby improving histopathological damage in the small intestine.Conclusion MFHD improves IgAN by regulating the gut microbiota—particularly by enriching Fusicatenibacter saccharivorans—thereby restoring the Th17/Treg immune balance and reducing IgA secretion.

Authors

Institutions

Publication Details

Journal
Renal Failure
Published
2026-11-18
DOI
https://doi.org/10.1080/0886022x.2026.2751280
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Modified Fangji Huangqi Decoction ameliorates IgA nephropathy by enriching Fusicatenibacter saccharivorans to rebalance Th17/Treg

Renhuan Yu, Qin Zeng, Wenru Wang, Xinhui Wang et al.
Renal Failure
Gut microbiota and health
article

Modified Fangji Huangqi Decoction ameliorates IgA nephropathy by enriching Fusicatenibacter saccharivorans to rebalance Th17/Treg

Renhuan Yu, Qin Zeng, Wenru Wang, Xinhui Wang, Ming Wang, Jiayi Yang, Lei Yan, Ying Liang
article en

Abstract

Background Abnormalities in mucosal immunity caused by gut microbiota dysbiosis are one of the key factors in the pathogenesis of IgA nephropathy (IgAN). Modified Fangji Huangqi Decoction (MFHD) is an effective treatment for IgAN, but it remains unclear whether its therapeutic effect is mediated by modulating the gut microbiota and thereby influencing mucosal immunity.Methods The chemical composition of MFHD was analyzed using UPLC-MS/MS. The renoprotective effects of different doses of MFHD on IgAN mice were evaluated by examining renal pathology and laboratory parameters. Additionally, a combination of metagenomics, flow cytometry, ELISA, and Western blot techniques was used to evaluate the effects of MFHD on the gut microbiota–mucosal immune axis. Potential functional bacterial species were identified through correlation analysis, and their effects were validated through strain transplantation experiments in a pseudo-germ-free mouse model.Results MFHD reduces urinary protein and improves renal pathological damage in IgAN mice. MFHD significantly increases gut microbiota diversity, enriches beneficial bacteria, and reverses the Th17/Treg immune imbalance, thereby reducing IgA+ plasma cells and serum IgA and IgG levels. Correlation analyses and strain transplantation experiment further confirmed that intestinal colonization by Fusicatenibacter saccharivorans restores the Th17/Treg balance and inhibits the differentiation of IgA+ plasma cells, thereby exerting a renoprotective effect. Additionally, both MFHD and Fusicatenibacter saccharivorans increase the expression of occludin and ZO-1, thereby improving histopathological damage in the small intestine.Conclusion MFHD improves IgAN by regulating the gut microbiota—particularly by enriching Fusicatenibacter saccharivorans—thereby restoring the Th17/Treg immune balance and reducing IgA secretion.

Renal FailureVol. 48(1)
Zhujiang Hospital (CN), Xiyuan Hospital (CN), China Academy of Chinese Medical Sciences (CN), Southern Medical University (CN)
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon